Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Dermatology
•
Bullous/Blistering Skin Disorders
What treatments can be combined for the treatment of immune checkpoint inhibitor induced toxic epidermal necrolysis?
Related Questions
What treatment combination approach would you recommend for mucous membrane pemphigoid?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
What is your approach to management of radiation-induced bullous pemphigoid?
What are your preferred treatment options for recalcitrant pemphigus vulgaris?
What is your stepwise approach to a patient with erosive gingivitis?
How often do you check desmoglien antibodies in pemphigus patients after treatment and during remission?
Would you utilize rituximab or dupilumab for treatment resistant bullous pemphigoid?
How often have you found patients complain about an infusion reaction to Remicade?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
